scholarly journals PReS-FINAL-2332: Activation-induced cell death of human monocytes as a novel mechanism fine-tuning inflammation and autoimmunity

2013 ◽  
Vol 11 (S2) ◽  
Author(s):  
M Miranda-García ◽  
J Däbritz ◽  
G Varga ◽  
T Weinhage ◽  
J Ehrchen ◽  
...  
2016 ◽  
Vol 46 (8) ◽  
pp. 1997-2007 ◽  
Author(s):  
Jan Däbritz ◽  
Toni Weinhage ◽  
Georg Varga ◽  
Timo Wirth ◽  
Jan M. Ehrchen ◽  
...  

2013 ◽  
Vol 11 (S1) ◽  
Author(s):  
M Miranda-Garcia ◽  
J Daebritz ◽  
G Varga ◽  
T Weinhage ◽  
J Ehrchen ◽  
...  

2021 ◽  
Vol 43 (1) ◽  
Author(s):  
Takahito Moriwaki ◽  
Akari Yoshimura ◽  
Yuki Tamari ◽  
Hiroyuki Sasanuma ◽  
Shunichi Takeda ◽  
...  

Abstract Background Peroxiredoxin 1 (PRDX1) is a member of a ubiquitous family of thiol peroxidases that catalyze the reduction of peroxides, including hydrogen peroxide. It functions as an antioxidant enzyme, similar to catalase and glutathione peroxidase. PRDX1 was recently shown act as a sensor of reactive oxygen species (ROS) and play a role in ROS-dependent intracellular signaling pathways. To investigate its physiological functions, PRDX1 was conditionally disrupted in chicken DT40 cells in the present study. Results The depletion of PRDX1 resulted in cell death with increased levels of intracellular ROS. PRDX1-depleted cells did not show the accumulation of chromosomal breaks or sister chromatid exchange (SCE). These results suggest that cell death in PRDX1-depleted cells was not due to DNA damage. 2-Mercaptoethanol protected against cell death in PRDX1-depleted cells and also suppressed elevations in ROS. Conclusions PRDX1 is essential in chicken DT40 cells and plays an important role in maintaining intracellular ROS homeostasis (or in the fine-tuning of cellular ROS levels). Cells deficient in PRDX1 may be used as an endogenously deregulated ROS model to elucidate the physiological roles of ROS in maintaining proper cell growth.


Cytotherapy ◽  
2021 ◽  
Vol 23 (5) ◽  
pp. S29
Author(s):  
M.J. Cox ◽  
C. Manriquez Roman ◽  
R. Sakemura ◽  
E. Tapper ◽  
E. Siegler ◽  
...  

Human Cell ◽  
2022 ◽  
Author(s):  
Tian Huan ◽  
Dongfeng Chen ◽  
Guodong Liu ◽  
Hailing Zhang ◽  
Xiaoyan Wang ◽  
...  

1997 ◽  
Vol 94 (11) ◽  
pp. 5778-5783 ◽  
Author(s):  
A. S. Varadhachary ◽  
S. N. Perdow ◽  
C. Hu ◽  
M. Ramanarayanan ◽  
P. Salgame

1995 ◽  
Vol 181 (1) ◽  
pp. 71-77 ◽  
Author(s):  
M R Alderson ◽  
T W Tough ◽  
T Davis-Smith ◽  
S Braddy ◽  
B Falk ◽  
...  

A significant proportion of previously activated human T cells undergo apoptosis when triggered through the CD3/T cell receptor complex, a process termed activation-induced cell death (AICD). Ligation of Fas on activated T cells by either Fas antibodies or recombinant human Fas-ligand (Fas-L) also results in cytolysis. We demonstrate that these two pathways of apoptosis are causally related. Stimulation of previously activated T cells resulted in the expression of Fas-L mRNA and lysis of Fas-positive target cells. Fas-L antagonists inhibited AICD of T cell clones and staphylococcus enterotoxin B (SEB)-specific T cell lines. The data indicate AICD in previously stimulated T cells is mediated by Fas/Fas-L interactions.


Sign in / Sign up

Export Citation Format

Share Document